About Bio pharmazeutika werden

The newest generation of biotechnological drugs, which are often created from living cells, are revolutionizing the way the medical conditions are treated. Bio pharmazeutika are not made with chemicals as traditional small-molecule drugs. They are made from many complex biological ingredients.

Biopharmazeutika werden are produced using gentechnische production (GTP) from in cultured bacteria, mammalian cells such as the popular CHO-Zellen, or even plants, which can be cultivated using plant biotechnology (Pflanzenbiotechnologie). In contrast to traditional pharmaceuticals that are created in the laboratory using chemical methods Biopharmazeutika are produced by living organisms and therefore must be distinguished by their own atom-by-atom bio pharmazeutika werden structure.

Because of their complexity biopharmazeutika cannot be replicated exactly by chemists. This is why they are characterized as biosimilars and not just generics. When the patent protection of an original drug expires, companies can produce their own versions of the drug to market, provided they are in compliance with certain statutory requirements, which are referred to as Biosimilar Guidelines.

Biopharmazeutika can be administered directly, or used as part of the manufacturing of a range of therapeutic devices including polysaccharides and peptides. As the process is processed downstream of Biopharmazeutika, these materials are recombined to form complex biological drugs. Recombinant biopharmazeutika includes insulin, interleukin and monoclonal antibody.